A detailed history of Manufacturers Life Insurance Company, The transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 260,355 shares of HALO stock, worth $11.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
260,355
Previous 265,236 1.84%
Holding current value
$11.9 Million
Previous $13.9 Million 7.25%
% of portfolio
0.01%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$51.3 - $64.42 $250,395 - $314,434
-4,881 Reduced 1.84%
260,355 $14.9 Million
Q2 2024

Aug 14, 2024

SELL
$37.81 - $52.4 $92,142 - $127,698
-2,437 Reduced 0.91%
265,236 $13.9 Million
Q1 2024

May 14, 2024

BUY
$33.68 - $41.95 $599,335 - $746,500
17,795 Added 7.12%
267,673 $10.9 Million
Q4 2023

Feb 13, 2024

SELL
$33.32 - $42.1 $137,378 - $173,578
-4,123 Reduced 1.62%
249,878 $9.24 Million
Q3 2023

Nov 15, 2023

BUY
$36.46 - $44.03 $1.24 Million - $1.49 Million
33,890 Added 15.4%
254,001 $9.7 Million
Q2 2023

Aug 11, 2023

SELL
$30.28 - $38.74 $30,461 - $38,972
-1,006 Reduced 0.45%
220,111 $7.94 Million
Q1 2023

May 15, 2023

SELL
$32.86 - $55.7 $75,216 - $127,497
-2,289 Reduced 1.04%
218,828 $8.36 Million
Q4 2022

Aug 11, 2023

SELL
$40.06 - $59.44 $636,673 - $944,679
-15,893 Reduced 6.71%
221,117 $12.6 Million
Q4 2022

Feb 13, 2023

SELL
$40.06 - $59.44 $636,673 - $944,679
-15,893 Reduced 6.71%
221,117 $12.6 Million
Q3 2022

Aug 11, 2023

SELL
$38.53 - $51.78 $383,103 - $514,848
-9,943 Reduced 4.03%
237,010 $9.37 Million
Q3 2022

Nov 03, 2022

SELL
$38.53 - $51.78 $383,103 - $514,848
-9,943 Reduced 4.03%
237,010 $9.37 Million
Q2 2022

Aug 11, 2023

SELL
$37.35 - $48.3 $32,046 - $41,441
-858 Reduced 0.35%
246,953 $10.9 Million
Q2 2022

Aug 15, 2022

SELL
$37.35 - $48.3 $32,046 - $41,441
-858 Reduced 0.35%
246,953 $11 Million
Q1 2022

Aug 11, 2023

BUY
$31.97 - $41.06 $926,586 - $1.19 Million
28,983 Added 13.24%
247,811 $9.88 Million
Q1 2022

May 20, 2022

BUY
$31.97 - $41.06 $683,294 - $877,575
21,373 Added 9.44%
247,811 $9.91 Million
Q4 2021

Feb 16, 2022

SELL
$31.82 - $40.75 $6.53 Million - $8.36 Million
-205,111 Reduced 47.53%
226,438 $9.11 Million
Q3 2021

Nov 12, 2021

BUY
$38.47 - $46.42 $8.01 Million - $9.67 Million
208,314 Added 93.32%
431,549 $17.6 Million
Q2 2021

Aug 12, 2021

BUY
$38.84 - $51.31 $319,187 - $421,665
8,218 Added 3.82%
223,235 $10.1 Million
Q1 2021

May 03, 2021

SELL
$39.51 - $51.45 $587,000 - $764,392
-14,857 Reduced 6.46%
215,017 $8.96 Million
Q4 2020

Feb 12, 2021

BUY
$25.81 - $43.62 $3.9 Million - $6.6 Million
151,245 Added 192.35%
229,874 $9.82 Million
Q3 2020

Nov 09, 2020

SELL
$25.74 - $29.63 $57,631 - $66,341
-2,239 Reduced 2.77%
78,629 $2.07 Million
Q2 2020

Aug 10, 2020

SELL
$16.25 - $26.81 $108,777 - $179,466
-6,694 Reduced 7.64%
80,868 $2.09 Million
Q1 2020

May 15, 2020

BUY
$13.9 - $21.83 $21,239 - $33,356
1,528 Added 1.78%
87,562 $1.58 Million
Q4 2019

Feb 14, 2020

SELL
$14.93 - $19.53 $44,327 - $57,984
-2,969 Reduced 3.34%
86,034 $1.53 Million
Q3 2019

Nov 12, 2019

SELL
$15.2 - $17.69 $4,438 - $5,165
-292 Reduced 0.33%
89,003 $1.35 Million
Q2 2019

Aug 14, 2019

BUY
$14.75 - $17.26 $103,073 - $120,612
6,988 Added 8.49%
89,295 $1.53 Million
Q1 2019

May 13, 2019

BUY
$13.94 - $17.58 $69,839 - $88,075
5,010 Added 6.48%
82,307 $1.33 Million
Q4 2018

Feb 14, 2019

SELL
$13.33 - $18.66 $57,385 - $80,331
-4,305 Reduced 5.28%
77,297 $1.13 Million
Q3 2018

Nov 14, 2018

SELL
$16.68 - $18.41 $11.7 Million - $12.9 Million
-703,299 Reduced 89.6%
81,602 $1.48 Million
Q2 2018

Aug 14, 2018

BUY
$16.87 - $20.3 $350,254 - $421,468
20,762 Added 2.72%
784,901 $13.2 Million
Q1 2018

May 15, 2018

BUY
$17.06 - $21.2 $813,028 - $1.01 Million
47,657 Added 6.65%
764,139 $15 Million
Q4 2017

Feb 08, 2018

SELL
$16.75 - $20.8 $2.35 Million - $2.91 Million
-140,093 Reduced 16.36%
716,482 $14.5 Million
Q3 2017

Nov 14, 2017

BUY
$11.76 - $17.4 $10.1 Million - $14.9 Million
856,575
856,575 $14.9 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.37B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.